Faculty of Medicine

Permanent URI for this communityhttps://repository.ukim.mk/handle/20.500.12188/14

Browse

Search Results

Now showing 1 - 3 of 3
  • Some of the metrics are blocked by your 
    Item type:Publication,
    EVALUATING A TRANSITORY RIGHT BUNDLE BRANCH BLOCK IN FOOTBALL PLAYER
    (Faculty of Physical Education, Sport and Health in Skopje, Republic of Macedonia, 2022)
    Janushevski, Filip
    ;
    Background: Athletic heart is a non-pathological condition. The occurrence of arrhythmias or branch block in athletes should be taken seriously. Cardiac examinations performed by an experienced cardiologist are crucial for defining the true condition of the athlete's heart and the eventual prevention of sudden cardiac death. Case report A professional football player at the age of 22 years with no personal or familial history of cardiovascular disease is referred to a cardiologist for abnormal treadmill test results. The treadmill test was impressive for the RBBB pattern on the electrocardiogram (ECG) that was not revealed on his basic and native ECG. As mentioned before he had no history of cardiovascular disease and he had been playing football skillfully for 10 years. This case report represents the importance of the electrocardiogram as a diagnostic tool in the evaluation of the athlete’s heart. Conclusion Despite consensus documents, recommendations and guidelines for electrocardiogram interpretation in athletes this method lacks specificity and sensitivity and sometimes further evaluation is needed for proper diagnosis and treatment.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World: The INCAPS-COVID Study
    (Elsevier BV, 2021-06-10)
    Hirschfeld, Cole B
    ;
    Shaw, Leslee J
    ;
    Williams, Michelle C
    ;
    Lahey, Ryan
    ;
    Villines, Todd C
    This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Metabolic Syndrome and Myocardial Infarction in Women
    (Bentham Science Publishers, 2021-04-29)
    Djuro Macut
    ;
    Sanja Ognjanovic
    ;
    Milka Ašanin
    ;
    Gordana Krljanac
    ;
    Abstract: Metabolic syndrome (MetS) represents a cluster of metabolic disorders that arise from insulin resis-tance (IR) and adipose tissue dysfunction. As a consequence, there is an increased risk for type 2 diabetes melli-tus and atherosclerotic cardiovascular disease (CVD). MetS is associated with a 2-fold increase in cardiovascu-lar outcomes. Earlier population analyses showed a lower prevalence of MetS in women (23.9%) in comparisonto men (27.8%), while later analyses suggest significantly reduced difference due to an increase in the preva-lence in women aged between 20 and 39. However, the prevalence of MetS in specific populations of women,such as in women with polycystic ovary syndrome, ranges from 16% to almost 50% in some geographical re-gions. Abdominal fat accumulation and IR syndrome are recognized as the most important factors in the patho-genesis of MetS. After menopause, a decline in insulin sensitivity corresponds to an increase in fat mass, circu-lating fatty acids, low-density lipoproteins, and triglycerides. Prevalence of MetS in acute coronary syndrome(ACS) is significantly more present in women (55.9%-66.3%) than in men (40.2%-47.3%) in different cohorts.Younger women with ACS had a higher mortality rate than younger men. Acute myocardial infarction (AMI)remains a leading cause of death in aging women. Women with AMI had significantly higher rates of prior con-gestive heart failure, hypertension history, and diabetes. The role of androgens in CVD pathogenesis in womenhas not yet been clarified. The current review aims to provide an insight into the role of MetS components andinflammation for the development of atherosclerosis, CVD, and AMI in women.